Equities

Pak Fah Yeow International Ltd

Pak Fah Yeow International Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)2.58
  • Today's Change-0.02 / -0.77%
  • Shares traded92.50k
  • 1 Year change+47.43%
  • Beta0.2020
Data delayed at least 15 minutes, as of Sep 20 2024 07:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pak Fah Yeow International Ltd is an investment holding company principally engaged in the manufacture and sale of healthcare products. The Company operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.

  • Revenue in HKD (TTM)265.21m
  • Net income in HKD96.45m
  • Incorporated1991
  • Employees101.00
  • Location
    Pak Fah Yeow International Ltd11th Floor, 200 Gloucester Road, Wanchai Hong KongHKG
  • Phone+852 28817713
  • Fax+852 25772895
  • Websitehttps://www.pakfahyeow.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Transcenta Holding Ltd24.63m-395.54m452.80m200.00--0.4229--18.39-0.974-0.9740.06072.460.01310.81060.5768114,540.40-21.08---29.77--26.02---1,606.19--1.04-31.650.2826---47.15---13.72------
Uni-Bio Science Group Ltd508.40m98.86m474.60m458.004.851.503.990.93350.01590.01590.08120.05141.272.239.051,249,140.0024.761.4632.971.9783.5180.5919.441.232.17168.550.22670.0010.0829.0884.04--84.98--
Tianda Pharmaceuticals Ltd384.68m-47.26m509.56m695.00--0.9358--1.32-0.022-0.0220.17890.25330.43412.974.46445,745.10-5.34---7.97--45.83---12.30--0.6748-9.510.1536--------------
3D Medicines Inc539.11m-495.99m557.73m198.00--0.5964--1.03-2.11-2.112.263.620.37464.945.792,722,764.00-37.27---50.88--91.97---99.50--2.56--0.2517--11.91--48.78------
Lee's Pharmaceutical Holdings Ltd1.20bn63.06m694.83m1.06k11.020.40553.540.57950.10710.10712.042.910.44032.119.701,134,410.001.9813.332.5217.7651.4961.924.5036.200.74256.120.1323.59-14.61-1.53-67.44-47.49-12.19-31.34
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd925.32m189.30m733.93m678.003.880.41995.780.79320.33790.33791.653.120.35742.102.941,091,177.007.317.6710.2510.4875.4678.7920.4620.681.62--0.05027.22-0.00495.38-23.43-1.67-1.14--
Zhaoke Ophthalmology Ltd63.10m-250.42m748.21m297.00--0.3337--11.86-0.4597-0.45970.11584.110.02331.250.8868201,601.40-9.23---10.51--82.03---396.86--5.48-24.020.1114------5.47------
Fusen Pharmaceutical Co Ltd469.27m-98.90m749.96m1.14k--1.31--1.60-0.1326-0.13260.62990.76540.32121.683.35408,769.60-6.770.9678-13.961.7453.1851.95-21.082.590.526-2.270.403127.9515.024.13-4.83--0.2124--
Jbm (Healthcare) Ltd648.42m130.46m756.24m279.006.220.78794.121.170.14790.14790.73381.170.46454.255.982,324,068.009.834.3812.045.5252.1446.4721.1612.691.2589.680.115532.9824.6216.09128.5119.992.26--
Pak Fah Yeow International Ltd265.21m96.45m804.03m101.008.341.077.753.030.30940.30940.85072.410.28692.8423.532,600,118.0010.443.9911.324.1887.0580.7936.3721.274.225.260.0055100.6876.0612.94250.6623.0218.83-8.06
Zhongzhi Pharmaceutical Holdings Ltd2.25bn122.77m820.42m2.74k6.550.67223.900.3640.1450.1452.661.411.092.686.10852,889.205.997.699.1711.7557.5560.445.496.730.903343.870.151642.4612.2612.4153.0013.8617.653.22
Hbm Holdings Ltd562.82m166.02m952.48m158.005.500.95124.851.690.22570.22570.76341.300.32583.9616.673,179,801.009.59-54.6113.25-66.0495.5797.8129.42-400.283.448.140.3502--120.13127.06116.61---12.62--
Ascletis Pharma Inc11.13m-285.07m997.39m219.00--0.4212--89.63-0.2746-0.27460.01072.370.00411.343.5850,813.03-10.47-6.43-10.85-6.64-125.1735.67-2,561.69-243.3824.31-4.180.004--4.63-19.3954.04---20.44--
Jacobson Pharma Corporation Ltd1.47bn210.24m1.18bn1.72k5.390.49253.350.8040.10950.13910.76441.200.33112.476.37851,885.104.744.305.765.5742.2741.2514.3213.731.735.330.238240.6215.79-0.14011.31-3.0524.064.10
Data as of Sep 20 2024. Currency figures normalised to Pak Fah Yeow International Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

5.00%Per cent of shares held by top holders
HolderShares% Held
Brooke Capital Ltd.as of 31 Dec 202315.58m5.00%
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.